We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

84 hedge funds and large institutions have $130M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $4.25M | Put options by funds: $1.71M

47.72% more ownership

Funds ownership: 0% → 47.72% (+48%)

Holders
84
Holders Change
+84
Holders Change %
–
% of All Funds
2.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
84
Increased
–
Reduced
–
Closed
–
Calls
$4.25M
Puts
$1.71M
Net Calls
+$2.54M
Net Calls Change
+$2.54M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

FRTX Hedge Fund Activity: Q2 2013 in Review

84 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2013, worth a combined $130M.

Buyers outnumbered sellers: 84 funds opened new FRTX positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.

  • 84 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $130M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 84 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +84 holders.

Based on aggregated 13F filings for Q2 2013.